FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a new compound, namely to (S)-enantiomer of 1'-{[5-(trifluoromethyl)furan-2-yl]methyl}spiro[furo[2,3-f][1,3]benzodioxol-7,3'-indole]-2'(1'H)-one of formula (I), and a method for preparing it which is effective for treating diseases and conditions, such as pain, an intensity of which can be reduced or relieved by modulating potential-dependent sodium channel gatings.
EFFECT: invention refers to the pharmaceutical composition of the above compound, methods of treating and a method of relieving an ion flux through the potassium channel gating in a cell.
10 cl, 5 tbl, 6 dwg, 11 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR LOCAL ADMINISTRATION AND USE THEREOF AS THERAPEUTIC AGENTS | 2011 |
|
RU2596488C2 |
SPIROHETEROCYCLIC COMPOUNDS AND USE THEREOF AS THERAPEUTIC AGENTS | 2006 |
|
RU2428424C2 |
PARALYTIC SHELLFISH POISON | 2013 |
|
RU2633637C2 |
PHARMACEUTICAL COMPOSITION CONTAINING GABAPENTIN OR ITS ANALOG AND α-AMINOAMIDE AND ITS USING AS ANALGESIC | 2002 |
|
RU2295337C2 |
KETOTHIPHEN OPTICALLY ACTIVE ISOMERS AND THEIR THERAPEUTICALLY ACTIVE METABOLITES | 2000 |
|
RU2266115C2 |
α -AMINOAMIDE DERIVATIVES APPLICABLE AS ANTI-INFLAMMATORY AGENTS | 2004 |
|
RU2396251C2 |
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION | 2011 |
|
RU2571284C2 |
AMINOPYRAZOLES AS SELECTIVE JANUS KINASE INHIBITORS | 2017 |
|
RU2757218C2 |
ARYL-SUBSTITUTED PYRAZOLES OR TRIAZOLES, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT, METHOD FOR REDUCING INTENSITY OR PROPHYLAXIS | 2001 |
|
RU2276141C9 |
PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND TRAMADOL FOR OPHTHALMIC APPLICATION | 2014 |
|
RU2694369C2 |
Authors
Dates
2014-12-20—Published
2010-06-28—Filed